MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine
about
Meningococcal B vaccine and the vision of a meningitis free worldEmerging experience with meningococcal serogroup B protein vaccines.Multicomponent meningococcal B vaccination (4CMenB) of adolescents and college students in the United StatesMeningococcal B vaccination: real-world experience and future perspectives.Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Portugal.Temporal Changes in BEXSERO® Antigen Sequence Type Associated with Genetic Lineages of Neisseria meningitidis over a 15-Year Period in Western Australia.Vaccine Potential and Diversity of the Putative Cell Binding Factor (CBF, NMB0345/NEIS1825) Protein of Neisseria meningitidis.Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisationImmunogenicity of a Meningococcal B Vaccine during a University Outbreak.Meningococcal serogroup B vaccines: Estimating breadth of coverage.Large Cluster of Neisseria Meningitidis Urethritis in Columbus, Ohio, 2015.Neisseria meningitidis infection: who, when and where?A review of guidance on immunization in persons with defective or deficient splenic function.Vaccine potential of bacterial macrophage infectivity potentiator (MIP)-like peptidyl prolyl cis/trans isomerase (PPIase) proteins.The next chapter for group B meningococcal vaccines.Need for Optimisation of Immunisation Strategies Targeting Invasive Meningococcal Disease in the Netherlands.Genomic analysis of urogenital and rectal Neisseria meningitidis isolates reveals encapsulated hyperinvasive meningococci and coincident multidrug-resistant gonococciNovel approaches to Neisseria meningitidis vaccine design.The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection.Differences in the population structure of Neisseria meningitidis in two Australian states: Victoria and Western Australia.Meningococcal Antigen Typing System (MATS)-Based Neisseria meningitidis Serogroup B Coverage Prediction for the MenB-4C Vaccine in the United States.Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines.Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010-2016.Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Isolated from 2009 to 2013 in the Republic of IrelandInvasive meningococcal disease in Shanghai, China from 1950 to 2016: implications for serogroup B vaccine implementation
P2860
Q26770696-007C46BB-D91E-47E4-937A-90C66746D8E9Q30234958-4D292DBF-8F45-4E8D-A6AA-B063CDDBB363Q30235072-D694085A-3E73-41F4-99EC-B2390E8E9C6AQ30249575-24483441-88F5-492B-8176-E0940BCA9558Q33620864-702050EA-62F9-48F2-84F7-509F22AC6DF7Q36064003-25801E98-DD29-431D-9E21-994F8D522D42Q36098758-2866425D-6F57-4434-9428-2F42A249864CQ36103475-3F49E827-4565-4828-93C4-4CC8ED819E06Q37192707-99DB389A-65EC-407A-B4C7-97431902D226Q37669413-9B71C93C-83CD-4CEE-AA69-A183FE7F2F0CQ37834261-4D01CA51-A25E-4788-A279-895C2E0517B6Q38550405-3D769B57-D8CA-48D7-8CBD-3BC92BB9AE5BQ38575340-3F23ADCB-90C8-4F64-B133-EFA6D95A254FQ38607614-E4DF2FBF-DF1F-4500-B626-D0F36A0F3F28Q38677309-487FB7FD-9D8C-4182-98D3-0DD62BF7F6C1Q38931495-CE3E1A88-9021-4431-8A09-364C48BF21F2Q38991142-F7453CC9-A61C-46D4-835C-BE6E4BD4A603Q39215403-AE27B608-3614-45E1-8941-B41A6BBFF0ECQ40461214-039E9479-F86F-44FC-8DB4-A09953B3F881Q43083529-01D490A8-0186-43A7-BF98-45A320E5C8AFQ45824896-F1BD88A5-8438-4120-83F9-74059655588EQ54233532-F36FB643-41E8-4B5D-874C-D26ACA61889AQ55154523-7596EC1E-24CA-484F-BBF5-2A1F93AE5D47Q57970428-2D578B92-4A1F-4321-AD09-0CE52D003FA8Q58771225-978F443E-D349-4609-9612-A5402685494A
P2860
MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
MATS: Global coverage estimate ...... ponent meningococcal B vaccine
@ast
MATS: Global coverage estimate ...... ponent meningococcal B vaccine
@en
MATS: Global coverage estimate ...... ponent meningococcal B vaccine
@nl
type
label
MATS: Global coverage estimate ...... ponent meningococcal B vaccine
@ast
MATS: Global coverage estimate ...... ponent meningococcal B vaccine
@en
MATS: Global coverage estimate ...... ponent meningococcal B vaccine
@nl
prefLabel
MATS: Global coverage estimate ...... ponent meningococcal B vaccine
@ast
MATS: Global coverage estimate ...... ponent meningococcal B vaccine
@en
MATS: Global coverage estimate ...... ponent meningococcal B vaccine
@nl
P3181
P1433
P1476
MATS: Global coverage estimate ...... ponent meningococcal B vaccine
@en
P2093
James Wassil
Maria Stella
P304
P3181
P356
10.1016/J.VACCINE.2015.04.015
P407
P577
2015-04-13T00:00:00Z